Analysis | Metabolite Name | Measured Value | Units | Treatment |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 848.5393192 | normalized | 2h TGF-β |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 1792.02473 | normalized | 2h TGF-β |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 2180.495334 | normalized | 2h TGF-β |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 2653.382588 | normalized | 2h ATP |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 2795.827532 | normalized | 2h ATP |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 3571.393825 | normalized | 2h ATP |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 4773.215017 | normalized | Control |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 5241.315741 | normalized | Control |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | 8832.547528 | normalized | Control |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | normalized | 2h ATP | |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | normalized | 2h TGF-β | |
Reversed phase POSITIVE ION MODE | CDP-DG(16:0/16:0) | normalized | Control |